Attorney General Kwame Raoul is spearheading a coalition of 37 states and territories, demanding the FDA crackdown on counterfeit weight loss and diabetes drugs that endanger consumers, with a focus on the GLP-1 category which includes Mounjaro, Zepbound, Ozempic, and Wegovy. These bad actors are taking advantage of people's desires for affordable health solutions, offering potentially harmful and illegal counterfeits
In a recent development, the bipartisan group issued a letter highlighting an alarming trend of illegitimate online retailers selling the active ingredients of these medications directly to consumers without a prescription, an act that not only disrespects the law but also poses significant health risks. These retailers market their products under the guise of 'research purposes only' or as 'not intended for human consumption', yet openly advertise to consumers on social media, claiming their offerings are a more convenient and budget-friendly option for obtaining GLP-1 drugs. According to the letter obtained by the Illinois Attorney General's website, "Consumers who purchase what they think is a product containing the active ingredients found in name-brand GLP-1 drugs run the risk of taking a counterfeit drug that was never intended for human consumption."
The coalition is pushing the FDA to ramp up enforcement against these deceitful practices and collaborate with state pharmacy boards to confirm that compounded GLP-1 medications are safely and sanitarily produced, as stated in Attorney General Raoul's letter, the authorities have the expertise and capability to put an end to these deceptive operations which, in some instances are offering products from unregulated, undisclosed sources that may contain dangerous contaminants or foreign substances.
Attorney General Raoul has already been proactive on the state level, in December 2024 his office sent cease and desist letters to five med spas in the Chicago area which were allegedly using misleading advertising potentially leading consumers to believe they were purchasing genuine GLP-1 meds, he also advises Illinois residents to be vigilant to avoid falling prey to counterfeit products, the bipartisan letter which Attorney General Raoul co-led with his counterparts from Colorado, South Carolina, and Tennessee was joined by a wide collection of state attorneys general, spanning from Alaska to Wisconsin, indicating a widespread concern over the issue.
Raoul urges the public to report any deceptive marketing or unsafe product sales through the Attorney General's website or by contacting the Consumer Fraud Hotlines, showcasing a commitment to consumer protection and a concerted effort to eliminate the hazardous counterfeit drug market.
